Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K6JQ
|
|||
| Former ID |
DIB012513
|
|||
| Drug Name |
INO-3401
|
|||
| Synonyms |
DNA vaccine (intradermal Cellectra electroporation, H5N1 influenza), Inovio
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza A virus H5N1 infection [ICD-11: 1E30] | Phase 1 | [1] | |
| Company |
Inovio pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human Deoxyribonucleic acid (hDNA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01405885) A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01403155) A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.